Qualigen Therapeutics, Inc. (QLGN)
NASDAQ: QLGN · Real-Time Price · USD
3.885
+0.075 (1.97%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Qualigen Therapeutics Employees
Qualigen Therapeutics had 4 employees as of December 31, 2023. The number of employees decreased by 34 or -89.47% compared to the previous year.
Employees
4
Change (1Y)
-34
Growth (1Y)
-89.47%
Revenue / Employee
n/a
Profits / Employee
-$1,985,305
Market Cap
2.86M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 4 | -34 | -89.47% |
| Dec 31, 2022 | 38 | -8 | -17.39% |
| Dec 31, 2021 | 46 | 8 | 21.05% |
| Dec 31, 2020 | 38 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novartis AG | 75,883 |
QLGN News
- 5 months ago - Univest Securities, LLC Announces Successful Closing of $5.1 Million Private Placement for Qualigen Therapeutics, Inc. (NASDAQ: QLGN) - GlobeNewsWire
- 6 months ago - Shares Expected to Begin Trading on Split-Adjusted Basis on November 5, 2024 - GlobeNewsWire
- 7 months ago - Qualigen Therapeutics, Inc. Announces management changes. - GlobeNewsWire
- 7 months ago - Qualigen Therapeutics, Inc. Received Extension from Nasdaq Hearings Panel - GlobeNewsWire
- 8 months ago - Univest Securities, LLC Announces Closing of $3.46 Million Registered Direct Offering for its Client Qualigen Therapeutics, Inc. (NASDAQ: QLGN) - GlobeNewsWire
- 8 months ago - Qualigen Therapeutics, Inc. Announces Closing of $3.47 Million Public Offering - GlobeNewsWire
- 8 months ago - Qualigen Therapeutics, Inc. Announces Pricing of $3.46 Million Public Offering - GlobeNewsWire
- 11 months ago - Qualigen Therapeutics, Inc. Received Nasdaq Notice of a Delisting Determination - GlobeNewsWire